Disclosure Of Interests In Other Entities [Text Block]

PureTech Health plc - Filing #5879297

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Subsidiary Preferred Shares
Disclosure of subsidiaries [text block]
Subsidiary Notes Payable
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests
25,728,000 USD
931,000 USD
13,290,000 USD
Non-controlling interests
6,774,000 USD
5,835,000 USD
Current assets
386,256,000 USD
347,201,000 USD
Non-current assets
216,379,000 USD
346,771,000 USD
Current liabilities
41,388,000 USD
51,370,000 USD
Non-current liabilities
153,314,000 USD
184,371,000 USD
Revenue
4,828,000 USD
3,330,000 USD
15,618,000 USD
Profit (loss)
53,510,000 USD
53,510,000 USD
25,728,000 USD
27,782,000 USD
66,628,000 USD
65,697,000 USD
931,000 USD
65,697,000 USD
37,065,000 USD
50,354,000 USD
13,290,000 USD
50,354,000 USD
Comprehensive income
53,510,000 USD
USD
53,510,000 USD
25,728,000 USD
27,782,000 USD
66,535,000 USD
65,604,000 USD
931,000 USD
65,697,000 USD
92,000 USD
37,444,000 USD
50,354,000 USD
13,290,000 USD
50,733,000 USD
379,000 USD
Gains (losses) recognised when control of subsidiary is lost
151,808,000 USD
61,787,000 USD
27,251,000 USD
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Investments in Associates
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
USD
92,000 USD
92,000 USD
92,000 USD
379,000 USD
379,000 USD
379,000 USD
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
280,641,000 USD
191,081,000 USD
149,866,000 USD
465,708,000 USD
Tax expense (income)
4,008,000 USD
30,525,000 USD
55,719,000 USD
Disclosure of investment entities [text block]
Disclosure of information about unconsolidated subsidiaries [text block]
Gain/(loss) on Deconsolidation of Subsidiary

Talk to a Data Expert

Have a question? We'll get back to you promptly.